More firms suffer from lackluster sales in first quarter

Published: 2013-05-15 06:59:00

Updated: 2013-05-15 06:59:00

Korea’s drug companies saw their first-quarter revenues drop compared to the last quarter due to the policy, geared toward eliminating the illegal kickbacks from drug firms to doctors and pharmacists.

According to the data released by the Financial Supervisory Service on Monday, nine of the 17...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK